NutraMax Cough/Cold Sales Increase 12% In First Quarter
This article was originally published in The Tan Sheet
Executive Summary
NutraMax sales for its cough/cold division increased 12% for the first quarter ended Jan. 2, despite last year's quarter finishing with one additional week. Comparing equivalent 13-week periods, sales in the cough/cold division increased 20%, the company said in a teleconference with securities analysts Jan. 26.